EX-10.2
from 10-Q
12 pages
Base Salary. During the Employment Term, the Company Shall Pay Executive an Initial Base Salary at the Annualized Rate of $439,700, Payable in Regular Installments in Accordance With the Company’s Usual Payment Practices. Executive’s Base Salary May Be Adjusted in the Sole Discretion of the Compensation Committee of the Board of Directors (The “Committee”). Executive’s Annual Base Salary, as in Effect From Time to Time, Is Hereinafter Referred to as the “Base Salary.” 4. Incentive Compensation
12/34/56
EX-10.13
from 10-K
3 pages
[*] = Certain Confidential Information Contained in This Document, Marked by Brackets, Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. October 6, 2023 • a Pro Rata Portion of the Actual Bonus That Would Have Been Earned for the Year of Termination, Based on the Days Employed During Such Year, Payable on the Date When Bonuses Are Otherwise Paid to Company Employees. • Full Acceleration of the Vesting of All Outstanding Equity Awards
12/34/56
EX-10.2
from 8-K
13 pages
Atossa Genetics Inc. 2345 Eastlake Ave. East, Suite 201 Seattle, Wa 98102 Gentlemen: The Undersigned (The “Investor”) Hereby Confirms Its Agreement With Atossa Genetics Inc., a Delaware Corporation (The “Company”), as Follows: 1. This Subscription Agreement, Including the Terms and Conditions for Purchase of Securities Attached Hereto as Annex I (Collectively, This “Agreement”) Is Made as of the Date Set Forth Below Between the Company and the Investor
12/34/56
